According to this new report, the global neurovascular intervention market is estimated to be valued at US$ 4.5 billion in the year 2028, growing at a CAGR of 9.42% in the period 2020 to 2028. Growth of the market is driven by the prevalence of cerebrovascular diseases and neurovascular disorders, favourable reimbursement policies and expanding healthcare infrastructure.
Neurovascular intervention is an approach for the treatment of neurological disorders and neurovascular diseases that affects the central nervous system. It is also used for the treatment of associated blood vascular systems using minimally invasive procedures. Neurological medical devices have been broadly classified into Neuro-stimulation Devices, Interventional Devices, Cerebral Spinal Fluid (CSF) Management Devices and Neurosurgery Devices.
Technological advancement in the neurovascular intervention industry has brought about a new treatment paradigm for patients suffering from neurovascular diseases. It has led to the deployment of surgical robots for the treatment of strokes. CorPath® GRX System, developed by Corindus, a Siemens Healthineers Company performed the first-in-human robotic-assisted neurovascular intervention in the year 2019.
Segments Covered
The report provides revenue forecasts for global, regional and country levels. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. For the purpose of research, the publisher has segmented global neurovascular intervention market report on the basis of geography, devices and application.
Device Outlook
Application Outlook
Regional Outlook
Country Outlook
Vendors Outlook
Target Audience
